Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide therapy has become a cornerstone of modern weight loss treatment, with studies showing sustained body weight reduction of 10-22% over 68 weeks in clinical trials. Understanding the true cost of compounded semaglutide requires looking beyond sticker price to see what's actually included in your monthly investment. PlexusDx breaks down the complete financial picture so patients can make informed decisions about their GLP-1 journey.

How Much Does Compounded Semaglutide Cost Monthly

PlexusDx offers compounded semaglutide injections starting at $149 per month across all commitment tiers. This flat pricing structure means your medication cost remains stable whether you're in month one or month twelve of treatment. Patients gain access to medications compounded by licensed 503A pharmacies that maintain pharmaceutical-grade standards without the brand-name markup.

The pricing philosophy at PlexusDx centers on one principle: your dose may need to go up, but your price won't. As your body adjusts and your provider increases your semaglutide dose during titration, you continue paying the same monthly rate. This transparency eliminates surprise billing and allows patients to budget accurately for their entire treatment course.

For those preferring oral administration, compounded oral semaglutide begins at $249 monthly. The oral option provides the same active ingredient with the convenience of tablet-based dosing, though bioavailability differs from injectable formulations. Both formats are manufactured through licensed compounding pharmacies serving all 50 states without requiring insurance coverage.

Microdose GLP-1 Protocol: The Most Affordable Starting Point

The Microdose GLP-1 Protocol at PlexusDx offers entry-level GLP-1 therapy at just $129 per month, making it the most accessible option for patients exploring weight loss medication for the first time. This protocol utilizes lower initial doses to minimize gastrointestinal side effects while maintaining metabolic benefit. Microdose formulations work well for patients with sensitivity to standard dosing or those seeking a gentler introduction to GLP-1 therapy.

Microdose protocols can be effective for modest weight loss goals and help identify patient tolerance before advancing to standard-dose formulations. Many patients experience meaningful appetite reduction and improved metabolic markers at lower dose ranges. The $129 monthly investment includes pharmacy consultation and access to PlexusDx's clinical support team throughout your treatment journey.

Comparing Semaglutide vs. Tirzepatide Pricing

Compounded tirzepatide injections start at $249 monthly, representing a $100 monthly difference from semaglutide injections. Tirzepatide activates both GLP-1 and GIP receptors, offering dual-pathway weight loss activation compared to semaglutide's single GLP-1 mechanism. Clinical trials demonstrate tirzepatide produces greater average weight loss—up to 22.5% body weight reduction—than semaglutide in head-to-head comparisons.

The GLP-Squared injection combining semaglutide and tirzepatide compounds begins at $249 monthly, matching tirzepatide's entry price while offering synergistic peptide activation. For oral preferences, tirzepatide tablets cost $279 monthly and GLP-Squared oral formulations start at $369 monthly. Choosing between these options depends on individual metabolic pathways, genetic predispositions, and treatment goals rather than price alone.

PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month to identify which compounds align with your genetic makeup. Testing reveals variations in GIPR, GLP1R, FTO, and MC4R genes that influence medication response and personalize your peptide selection for maximum efficacy.

What's Included in Your Monthly PlexusDx Investment

PlexusDx pricing covers the medication itself plus access to pharmacy consultation and clinical support at no additional charge. Patients receive guidance on injection technique, side effect management, and dosage progression throughout treatment. All medications ship directly to your home with temperature-controlled packaging ensuring potency upon arrival.

There are no hidden membership fees, insurance requirements, or mandatory telehealth consultations beyond initial assessment. HSA and FSA accounts can cover all PlexusDx medications and the genetic testing add-on, reducing out-of-pocket expenses for eligible patients. The company's transparent billing means your monthly statement reflects your actual cost with no surprise adjustments.

Payment Options and Insurance Coverage at PlexusDx

PlexusDx serves patients regardless of insurance status, accepting direct payment and HSA/FSA accounts as primary payment methods. For uninsured patients, the fixed monthly pricing creates predictable healthcare budgeting without deductibles or prior authorization delays. Insurance carriers don't cover compounded medications in most cases, making direct-pay enrollment often more cost-effective than navigating traditional insurance routes.

Payment plans and flexible commitment tiers allow patients to adjust their financial strategy based on treatment progress. Whether committing to a single month or locking in multiple months for consistency, PlexusDx maintains the same transparent pricing structure. Setting up automatic monthly billing through the patient portal streamlines refill management and ensures uninterrupted medication access.

Why Licensed 503A Compounding Affects Your Total Cost

PlexusDx exclusively partners with licensed 503A compounding pharmacies rather than 503B facilities, maintaining pharmaceutical-grade quality standards that justify pricing relative to brand-name alternatives. 503A compounders operate under state pharmacy board oversight and FDA facility inspection protocols, ensuring sterility and potency. This regulatory framework adds legitimate cost compared to bulk manufacturing but provides personalization impossible in mass production.

Compounded medications allow dosage flexibility and formulation customization impossible with pre-manufactured options. Patients requiring specific injection volumes, concentration adjustments, or combination compounds benefit from 503A capabilities. The cost difference between compounded and brand products often narrows when factoring in personalization benefits and elimination of insurance middlemen.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does PlexusDx charge more for higher semaglutide doses?

No. PlexusDx pricing remains flat regardless of dose level. Your compounded semaglutide injection costs $149-$189 monthly whether you're taking 0.25mg or 2.4mg weekly. This structure ensures predictable budgeting throughout your entire titration schedule.

How much weight loss can I expect from compounded semaglutide?

Clinical trials show semaglutide produces average weight loss of 10-22% of body weight over 68 weeks, depending on individual factors. Results vary based on diet, exercise, genetics, and baseline metabolic health. PlexusDx offers genetic testing to identify your peptide pathway potential for personalized outcome estimates.

Is the Microdose GLP-1 Protocol effective for significant weight loss?

The Microdose protocol at $129 monthly suits patients with GLP-1 sensitivity, mild weight loss goals, or those testing tolerance before advancing. While lower doses produce modest results compared to standard formulations, many patients achieve meaningful appetite suppression and metabolic improvements.

Can I use HSA or FSA to pay for PlexusDx semaglutide?

Yes. All PlexusDx medications, including compounded semaglutide and tirzepatide, qualify for HSA and FSA coverage. The Precision Peptide Genetic Test add-on ($99) also counts as an eligible medical expense, reducing your out-of-pocket liability significantly.

What does the Precision Peptide Genetic Test reveal about my semaglutide response?

PlexusDx's genetic test analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that influence GLP-1 medication effectiveness.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves